Future prevention and treatment of diabetic neuropathy

Diabetes and Metabolism

Volumn 24, Issue SUPPL. 3, 1998, Pages 79-83

  Tomlinson, D R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Nerve growth factor; Neuropathy; Neurotrophin 3; Neurotrophins; Non enzymatic glycation; Oxidative stress; Polyol pathway

Indexed keywords

GAMMA LINOLENIC ACID; NERVE GROWTH FACTOR; NEUROTROPHIN 3; POLYOL; SORBITOL; THIOCTIC ACID;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN GLYCOSYLATION;

DIABETIC NEUROPATHIES; FORECASTING; GLYCOSYLATION; HUMANS; HYPERGLYCEMIA; NERVE GROWTH FACTORS; OXIDATIVE STRESS; SORBITOL;

EID: 0032423134     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med, 1993, 329, 977-986.
2. Diabetes Control and Complications Trial Research Group. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes, 1988, 37, 476-481.
3. Pirart J. Diabète et complictions dégéneratives : présentation d'une étude prospective portant sur 4 400 cas observés entre 1949-1973. Diabète Métab, 1977, 3, 97-107.
4. Monboisse JC, Gillery P, Maquart FX, Borel JP. Production of superoxide anion by glycated proteins : Involvement in complications of diabetes mellitus. Adv Exp Med Biol, 1990, 264, 551-554.
5. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products : a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun, 1990, 173, 932-939.
6. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol Med, 1991, 10, 339-352.
7. Yeh LA, Ashton MA. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil. Metabolism, 1990, 39, 619-622.
8. Nagaraj RH, Prabhakaram M, Ortwerth BJ, Monnier VM. Suppression of pentosidine formation in galactoscmic rat lens by an inhibitor of aldose reductase. Diabetes, 1994, 43, 580-586.
9. Ou P, Nourooz-Zadeh J, Tritschler HJ, Wolff S. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid. Free Radic Res, 1996, 25, 337-346.
10. Bravi MC, Pietrangeli P, Laurenti O, et al. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism, 1997, 46, 1194-1198.
11. Tomlinson DR, Holmes PR, Mayer JH. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neuro-sci Lett, 1982, 57, 189-193.